Hepatitis C in liver transplantation
|
Hepatitis C |
|
Diagnosis |
|
Treatment |
|
Hepatitis C in liver transplantation On the Web |
|
American Roentgen Ray Society Images of Hepatitis C in liver transplantation |
|
Risk calculators and risk factors for Hepatitis C in liver transplantation |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2]
Recommendations for Diagnosis and Treatment of HCV-Infected Children: AASLD Practice Guidelines 2009[1]
| “ |
1.Treatment of HCV-related disease following liver transplantation should be initiated in appropriate candidates after demonstration of recurrent histologic disease but should be undertaken with caution and under the supervision of a physician experienced in transplantation (Class IIa, Level A). 2. Peginterferon alfa either with or without ribavirin should be the preferred regimen when treating patients with hepatitis C after liver transplantation (Class IIa, Level B). 3. Interferon-based therapy should not be used in recipients of heart, lung, and kidney grafts, except for patients who develop fibrosing cholestatic hepatitis (Class III, Level C). |
” |
References
- ↑ Swan T, Curry J (2009). "Comment on the updated AASLD practice guidelines for the diagnosis, management, and treatment of hepatitis C: treating active drug users". Hepatology (Baltimore, Md.). 50 (1): 323–4, author reply 324–5. doi:10.1002/hep.23077. PMID 19554546. Retrieved 2012-02-21. Unknown parameter
|month=ignored (help)